1. Stocks
    2. /
  2. Merck (NYSE: MRK)
    3. /

Merck (NYSE: MRK) Share Price and News

$101.64 $-1.48 (-1.4%) Saturday, 30 November 2024 at 5:00:02 am Australian Eastern Daylight Time

Merck Chart and Price Data

About Merck

Last updated 30-11-2024, 05:00:02am AEDT
Current Price $101.64
Change $-1.48 (-1.4%)
Close Price $101.64
Open Price $102.88
Bid $101.46
Ask $101.70
Day Range $101.53 - $103.04
Year Range $94.48 - $134.63
Volume 1,279
Average Volume 10,451,852
Market Cap $257,112,609,600.00
Earnings Per Share $4.77

    • Merck (NYSE: MRK)
    Latest News

    Dollar signs floating in the sea.
    International Stock News

    The Dow got crushed — Here are 4 stocks that survived the bloodbath

    | Bram Berkowitz

    The Dow Jones Industrial Average fell more than 740 points today.

    Read more »

    Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
    Healthcare Shares

    Imugene (ASX:IMU) share price lifts on major collaboration announcement

    | Bernd Struben

    The clinical trial will evaluate the safety and efficacy of a combination drug treatment approach in cancer patients.

    Read more »

    Legendary share market investing expert and owner of Berkshire Hathaway Warren Buffett
    International Stock News

    Here are the shares that Warren Buffett has been buying (and selling) lately

    | Sebastian Bowen

    Want to know what shares the world's greatest investor Warren Buffett, of Berkshire Hathaway, has been buying and selling? Look…

    Read more »

    Legendary share market investing expert and owner of Berkshire Hathaway Warren Buffett
    International Stock News

    Warren Buffett bought 4 pharma giants in Q3

    | Brian Orelli, PhD

    The Oracle of Omaha and his team opened new positions in the underperforming sector.

    Read more »

    row of piggy banks with large one receiving injection representing rising Immutep share price
    Share Market News

    Immutep (ASX:IMM) share price flying 20% on improving trials

    | Daniel Ewing

    The Immutep share price is flying today as the company reported improvements in trials relating to its leading drug IMP321.

    Read more »

    a woman
    ⏸️ ASX Shares

    Experts are tipping these healthcare shares for big things

    | James Mickleboro

    Here are two healthcare picks from analysts at Antipodes Global Investment Company Ltd (ASX:APL) and Goldman Sachs...

    Read more »

    Profile

    since

    Note